UB
UBE.F Ube Industries Ltd
- Market cap
- EUR 1.81B
- P/E
- 14.1x
- P/B
- 0.72x
- ROE
- 4.7%
- Dividend yield
- 4.93%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.
Is UBE.F undervalued?
Graham numberUBE.F trades 33.1% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ube Industries Ltd fundamental analysis
No fundamental analysis for Ube Industries Ltd yet.
Ube Industries Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ube Industries Ltd
UBE Corporation, together with its subsidiaries, engages in the materials and machinery businesses in Japan, Asia, Europe, North America, and internationally. The company operates through Functional Products, High-Performance Urethanes, Pharmaceuticals, Resin and Chemical Products, Machinery, and Others segments. Its Functional Products segment offers polyimides, separation membranes, ceramics, and separators. The High-Performance Urethanes segment provides urethane resin in…
Full company profileUbe Industries Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Ube Industries Ltd annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 617B | 696B | 730B | 668B | 614B | 655B | 495B | 468B | 487B | 462B | 489B |
| Gross Profit | 116B | 135B | 130B | 118B | 105B | 128B | 82.6B | 86.7B | 90.9B | 103B | 119B |
| Operating Income | 35.0B | 50.3B | 44.6B | 34.0B | 25.9B | 44.0B | 16.3B | 22.5B | 18.0B | 18.9B | 24.3B |
| EBITDA | - | 81.8B | 82.2B | 68.2B | 59.7B | 74.2B | 23.6B | 62.8B | 18.3B | 61.7B | 72.0B |
| Net Income | 24.2B | 31.7B | 32.5B | 23.0B | 22.9B | 24.5B | -7.01B | 29.0B | -4.82B | 23.9B | 20.9B |
| EPS | 228 | 302 | 322 | 227 | 227 | 253 | -72 | 299 | -50 | 246 | 215 |
| Balance Sheet | |||||||||||
| Total Assets | 709B | 743B | 740B | 727B | 770B | 838B | 732B | 789B | 866B | 946B | 950B |
| Total Liabilities | 399B | 406B | 386B | 373B | 389B | 444B | 350B | 360B | 454B | 491B | 490B |
| Shareholders' Equity | 287B | 316B | 330B | 333B | 360B | 370B | 362B | 409B | 395B | 437B | 443B |
| Cash & Short-term Investments | 36.6B | 49.1B | 32.9B | 41.2B | 80.3B | 79.5B | 31.2B | 36.4B | 116B | 55.8B | 61.9B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 53.4B | 73.4B | 50.5B | 68.5B | 66.1B | 32.7B | 18.1B | 53.0B | 35.8B | 60.0B | 38.8B |
| Capital Expenditure | 41.9B | 33.8B | 42.8B | 42.7B | 38.2B | 36.4B | 26.8B | 31.0B | 58.9B | 72.4B | 62.0B |
| Free Cash Flow | - | 39.6B | 7.70B | 25.8B | 27.8B | -3.67B | -8.70B | 22.0B | -23.1B | -12.5B | -23.1B |
| Ratios | |||||||||||
| ROE | 8.4% | 10.0% | 9.8% | 6.9% | 6.4% | 6.6% | -1.9% | 7.1% | -1.2% | 5.5% | 4.7% |
| ROA | 3.4% | 4.3% | 4.4% | 3.2% | 3.0% | 2.9% | -1.0% | 3.7% | -0.6% | 2.5% | 2.2% |
| Net Profit Margin | 3.9% | 4.6% | 4.5% | 3.4% | 3.7% | 3.7% | -1.4% | 6.2% | -1.0% | 5.2% | 4.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Ube Industries Ltd dividends
- Dividend yield
- 4.93%
- Forward dividend
- 0.90 EUR
- Payout ratio
- 44.6%
- Ex-dividend date
- Mar 30, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 10.7B | 110 | 44.6% |
| 2025 | JPY 10.6B | 110 | - |
| 2024 | JPY 9.19B | 95 | 31.7% |
| 2023 | JPY 9.67B | 100 | - |
| 2022 | JPY 8.92B | 92 | 36.4% |
| 2021 | JPY 9.09B | 90 | 39.6% |
| 2020 | EUR 12.6B | 125 | 54.9% |
| 2019 | EUR 7.88B | 78 | 24.2% |
| 2018 | EUR 6.35B | 60 | 20.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:10 on Sep 27, 2017.
Who owns Ube Industries Ltd
- Insiders 0.65%
- Institutions 44.42%
- Public & others 54.93%
- Shares outstanding 97.2M
- Free float 97.0M
Ube Industries Ltd company profile
- Company name
- Ube Industries Ltd
- Ticker
- UBE.F
- ISIN
- JP3158800007
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 7,968
- Fiscal year end
- March
- Address
- Seavans North Building, Minato, Japan, 105-8449
- Phone
- 81 3 5419 6112
- Website
- ube.com
About Ube Industries Ltd
UBE Corporation, together with its subsidiaries, engages in the materials and machinery businesses in Japan, Asia, Europe, North America, and internationally. The company operates through Functional Products, High-Performance Urethanes, Pharmaceuticals, Resin and Chemical Products, Machinery, and Others segments. Its Functional Products segment offers polyimides, separation membranes, ceramics, and separators. The High-Performance Urethanes segment provides urethane resin intermediate, elastomers, and coating products. Its Pharmaceuticals segments engages in the drug discovery and the contract manufacturing and sales of pharmaceutical raw materials and intermediates. The Resin and Chemical Products segment provides composite, nylon polymer, caprolactam, ammonium sulfate, industrial chemicals, and elastomer. Its Machinery segment offers die casting machines, extrusion presses, injection molding machines, ceramics machinery, chemical equipment, crushers, transport machines, dust removers, as well as bridges, steel structures, etc. The Other segment is involved in electricity supply, real estate sales, leasing, and management, etc. The company was formerly known as Ube Industries, Ltd. UBE Corporation was founded in 1897 and is headquartered in Minato, Japan.
Ube Industries Ltd management
10- Mr. Yuki NishidaPresident, CEO & Representative Director · born 1962
- Mr. Hirotaka IshikawaCFO, CRO, Managing Executive Officer & Representative Director · born 1965
- Mr. Yoichi YoshidaCTO & Executive Officer
- Shinsuke TokumitsuGeneral Manager of Investor & Public Relations Department
- Mr. Ryo KawamuraManaging Executive Officer, CHRO, CCO & Director · born 1967
- Shuko HorieGeneral Manager of Corporate Communications Department
- Hisaaki YokooSenior Managing Executive Officer & GM of Elastomer Div.
- Yoichi FunayamaSenior Managing Executive Officer & GM of Specialty Products Div
- Futoshi TakaseManaging Executive Officer, GM of Production Division & Director of Ube Plant
- Shinya TakahashiManaging Executive Officer & Chief Strategy Officer